These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31398515)

  • 1. Treatment of Bowen's disease with photodynamic therapy. Observational study in 171 patients with 5-aminolaevulinic acid (BF-200 ALA) and methyl aminolaevulinate (MAL).
    Alique-García S; Alique D; Company-Quiroga J; Sánchez A; Núñez AH; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():192-194. PubMed ID: 31398515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial basal cell carcinoma with photodynamic therapy. Observational study in 22 patients with 5-aminolaevulinic acid and methyl aminolaevulinate.
    Alique-García S; Company-Quiroga J; Sánchez Campos A; Hernández Núñez A; Borbujo J
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():190-192. PubMed ID: 30914392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
    Ibbotson SH; Valentine R; Hearn R
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option?
    Morton CA
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S21-2; discussion S23-5. PubMed ID: 15859305
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017).
    Aguilar-Bernier M; Rodríguez-Barón D; Rivas-Ruiz F; Segura-Palacios JM; de Troya Martín M
    Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):208-213. PubMed ID: 30690796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
    Gómez C; Cobos M; Alberdi E
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():295-299. PubMed ID: 30986539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Photodynamic Therapy for Bowen's Disease Using Plum-Blossom Needling to Augment Drug Delivery.
    Wu Y; Wang P; Zhang L; Wang B; Wang X
    Dermatol Surg; 2018 Dec; 44(12):1516-1524. PubMed ID: 29994952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
    Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease.
    Cai H; Wang YX; Zheng JC; Sun P; Yang ZY; Li YL; Liu XY; Li Q; Liu W
    Lasers Med Sci; 2015 Jul; 30(5):1505-10. PubMed ID: 25899562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
    Morton CA; Dominicus R; Radny P; Dirschka T; Hauschild A; Reinhold U; Aschoff R; Ulrich M; Keohane S; Ekanayake-Bohlig S; Ibbotson S; Ostendorf R; Berking C; Gröne D; Schulze HJ; Ockenfels HM; Jasnoch V; Kurzen H; Sebastian M; Stege H; Staubach P; Gupta G; Hübinger F; Ziabreva I; Schmitz B; Gertzmann A; Lübbert H; Szeimies RM
    Br J Dermatol; 2018 Aug; 179(2):309-319. PubMed ID: 29432644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy in the treatment of extensive Bowen's disease.
    López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
    J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
    Farhi D; Bedane C; Savary J; Basset-Seguin N
    Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Hahn S; Pabst G; Voss D; Foguet M; Schmitz B; Lübbert H; Szeimies RM; ;
    Br J Dermatol; 2013 Apr; 168(4):825-36. PubMed ID: 23252768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
    Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
    Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How we treat Bowen's disease with topical photodynamic therapy in Dundee.
    Attili SK; Ibbotson SH
    Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):41-5. PubMed ID: 19447370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
    Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
    Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.